KR100372233B1 - Skin-whitening powder, preparation process thereof and skin-whitening makeup cosmetic containing the same powder - Google Patents

Skin-whitening powder, preparation process thereof and skin-whitening makeup cosmetic containing the same powder Download PDF

Info

Publication number
KR100372233B1
KR100372233B1 KR1019970008310A KR19970008310A KR100372233B1 KR 100372233 B1 KR100372233 B1 KR 100372233B1 KR 1019970008310 A KR1019970008310 A KR 1019970008310A KR 19970008310 A KR19970008310 A KR 19970008310A KR 100372233 B1 KR100372233 B1 KR 100372233B1
Authority
KR
South Korea
Prior art keywords
whitening
skin
powder
makeup
weight
Prior art date
Application number
KR1019970008310A
Other languages
Korean (ko)
Other versions
KR19980073162A (en
Inventor
이건국
Original Assignee
주식회사 코리아나화장품
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 코리아나화장품 filed Critical 주식회사 코리아나화장품
Priority to KR1019970008310A priority Critical patent/KR100372233B1/en
Publication of KR19980073162A publication Critical patent/KR19980073162A/en
Application granted granted Critical
Publication of KR100372233B1 publication Critical patent/KR100372233B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/412Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE: A skin-whitening powder, a preparation process thereof and a skin-whitening makeup cosmetic containing the same powder are provided to prepare the skin-whitening cosmetic having improved skin-whitening effect, makeup effect and utility. CONSTITUTION: The skin-whitening powder is prepared by adsorbing a skin-whitening material to titanium dioxide silica, and coating the skin-whitening material adsorbed with silicone copolymer, wherein the skin-whitening material is harounoside; the silicone copolymer is selected from trimethyl polysiloxane, methyl hydrogen polysiloxane, and bridge type methyl polysiloxane. The process for preparing the skin-whitening powder comprises the steps of: adsorbing 5 to 25 wt.% of 50% whitening material to 70 to 94.5 wt.% of titanium dioxide silica having particle diameter of 2 to 30 micrometer; coating it with 0.5 to 5 wt.% of silica copolymer; maturing the whitening material complex at 100 to 150 deg. C and the atmospheric pressure of 800 to 1000 for 24 to 48 hours; and pulverizing the matured whitening material complex in twice and hydrophobic treating it. The skin-whitening makeup cosmetic contains 1 to 20 wt.% of the skin-whitening powder.

Description

미백 파우더, 그의 제조방법 및 그를 함유하는 메이크업 미백 화장료Whitening powder, preparation method thereof, and makeup whitening cosmetic containing same

본 발명은 미백 파우더에 관한 것으로, 구체적으로는 미백효과가 우수하고 화장효과 및 사용성이 우수한 미백 파우더, 그의 제조방법 및 그를 함유하는 메이크업 미백 화장료에 관한 것이다.The present invention relates to a whitening powder, and more particularly, to a whitening powder having an excellent whitening effect and excellent make-up effect and usability, a preparation method thereof, and a makeup whitening cosmetic containing the same.

피부는 자외선으로 신체를 보호하는 기능을 가진다. 즉, 자외선이 조사되면 멜라닌 형성 세포(Melanocyte)내에서 티로시나아제(tyrosinase)의 활성이 증가되어 흑색의 멜라닌 색소가 생성되고 방출되어 표피세포에 분포함으로써, 자외선을 차단하는 자연적인 스크리닝 기능을 하게 되는 것이다. 이때 자외선과 티로시나아제는 멜라닌 생성 경로에서 가장 핵심적인 역할을 하는데, 특히 멜라닌 형성 세포에서 티로시나아제의 활성이 촉진되면 멜라닌 생성이 증가되어 결국 피부가 검게되어 자외선을 차단하게 된다.The skin has the function of protecting the body from ultraviolet rays. That is, when the ultraviolet light is irradiated, the activity of tyrosinase is increased in melanocytes, which produce and release black melanin pigments, which are distributed on the epidermal cells, thereby blocking the natural screening function. Will be. At this time, ultraviolet rays and tyrosinase play a key role in the melanin production pathway. In particular, when the activity of tyrosinase is promoted in melanin-forming cells, melanin production is increased and eventually the skin becomes black to block ultraviolet rays.

그러나 멜라닌 색소의 과다한 생성 및 침착은 피부의 흑화, 기미, 주근깨 등의 피부질환을 유발한다.However, excessive production and deposition of melanin pigment causes skin diseases such as blackening of the skin, blemishes, and freckles.

이에 따라 피부의 흑화, 기미, 주근깨 등의 피부질환을 막기위하여 미백 화장료가 요구되고 있다.Accordingly, whitening cosmetics are required to prevent skin diseases such as blackening of the skin, blemishes, and freckles.

그리나 기존의 미백 화장료는 안정성이 불량하고 이로인해 미백효과가 불명확하며 안정성이 떨어지는 문제점이 있으며, 특히 기존의 메이크업 미백 화장료는 미 백효과가 감소하는 문제점이 있다. 즉 현재 미백 화장료는 미백물질로 주로 아스콜빈산(특개평 4-9320), 코지산(일본 특공 56-18569), 코지산 유도체(일본 특개 56-7710), 하이드로 퀴논(특개평 6-192062), 알부틴(특개평 4-9315) 및 일부의 식물 추출물 등이 사용되고 있는데, 코직산과 아스코르빅산은 매우 불안정해서 이를 소량 함유한 화장료는 실온에서 수주일간 보관하면 갈변현상이 일어나며, 알부틴도 세포독성을 일으켜 안전성이 문제되고 있다. 또한, 기존의 메이크업 미백 화장료는 기존 미백 물질들이 메이크업 화장료의 안료와 흡착하거나 반응을 일으켜 멜라닌 생성 억제 효과가 감소하게 한다.However, the existing whitening cosmetics have a problem of poor stability and thereby the whitening effect is unclear and the stability is inferior. In particular, the conventional makeup whitening cosmetics has a problem of decreasing the whitening effect. Currently, whitening cosmetics are whitening substances, mainly ascorbic acid (JP-A 4-9320), koji-san (JP-A-56-18569), kojic acid derivatives (JP-A-56-7710), and hydroquinone (JP-A 6-192062). , Arbutin (JP-A 4-9315) and some plant extracts are used. Kojic acid and ascorbic acid are very unstable, and cosmetics containing small amounts of browning occur for several weeks at room temperature. It raises, and safety is a problem. In addition, the existing make-up whitening cosmetics to reduce the effect of inhibiting melanin production by causing the existing whitening materials to adsorb or react with the pigment of the makeup cosmetics.

한편 메이크업 화장은 일반적으로 은폐성, 색감표현성, 보습성 및 자외선 차단에 의한 미백효과 등의 화장효과가 우수하여야 하고, 화장효과의 지속성, 피부 부착성이나 피부유연성 등의 사용성이 좋아야 하며, 물이나 땀에 의하여 잘 지워지지 않는 등 내수성이 우수하여야 하고, 안정성이 높은 것이 요구된다.On the other hand, make-up make-up generally should have excellent makeup effects such as concealment, color expression, moisturizing and whitening effect by UV protection, and should have good usability such as persistence of makeup effect, skin adhesion or skin flexibility. It should be excellent in water resistance, such as not being easily erased by sweat, and high stability is required.

종래에는 주로 수중유적 유화형 화장품이 사용되었으나 그 화장효과가 오래 지속되지 못했으며 특히 내수성이 미비하여 화장을 하고 난 후에 얼룩이 생기거나 또한 화장이 지워지기 쉬었다. 이러한 단점을 보완하기 위해 유중수적 유화형 메이크업 화장품이 사용되었는데 내수성은 크게 증가되었으나 땀이 많고 물과의 접촉이잦은 여름철이나 운동시에는 내수성이 충분하지 못하였고 화장의 지속성 및 안정성도 만족스럽지 못하였으며 사용할 때 피부에 닿는 촉감도 좋지 못한 등의 단점이 있었다.Conventionally, oil-in-water oil-based cosmetics have been mainly used, but the cosmetic effect has not lasted for a long time, and especially water resistance is inadequate to make stains or to easily remove makeup after makeup. Water-in-oil emulsified make-up cosmetics were used to compensate for these shortcomings, but the water resistance was greatly increased, but the water resistance was not enough during the summer or exercise when there was a lot of sweat and contact with water, and the persistence and stability of the makeup was not satisfactory. When used, there was a disadvantage such as poor skin touch.

한편, 국내 특허 공고 제 85-1298호에는 무기안료나 표면이 친유성을 갖도록 처리된 무기안료에 오일 결합체를 분무 분쇄시킨 후, 여기에 다시 실리콘 오일을 분무 분쇄하여 압축시켜서 화운데이션을 제조하는 기술이 소개되어 있으나, 이는 단지 내수성 증가만 가져왔고, 다른 안료와는 상용성이 좋지 못하여 안정성이 매우 저하된 문제점이 있었으며, 친수적으로 된 미백 물질을 화장료에 사용하기에는 더욱 어려운 점이 있었다.On the other hand, Korean Patent Publication No. 85-1298 discloses a technique for preparing foundations by spray-pulverizing oil conjugates to inorganic pigments or inorganic pigments treated to have a lipophilic surface, and then spray-pulverizing and compressing silicone oil. Introduced, but it only brought an increase in water resistance, there was a problem that the stability is very poor due to poor compatibility with other pigments, it was more difficult to use a hydrophilized whitening material in cosmetics.

이에 본 발명자들은 미백물질로 멜라닌 생성 억제 물질을 선택하고 이를 메이크업 화장료에 안정하게 배합하는 방법, 내수성 및 피부부착성을 증가시키는 방법들에 대하여 연구하여, 미백효과, 자외선 차단 효과, 내수성 및 퍼짐성, 화장지속성 등 화장효과 및 사용성이 모두 우수한 새로운 메이크업 미백 화장료를 개발하고자 하였다.Therefore, the present inventors have selected a melanin production inhibitor as a whitening material and a method of stably compounding it in makeup cosmetics, methods for increasing the water resistance and skin adhesion, and the whitening effect, UV protection effect, water resistance and spreadability, We tried to develop new makeup whitening cosmetics with excellent makeup effect and usability.

본 발명의 목적은 미백 효과가 우수하며 동시에 화장효과 및 사용성이 개선된 새로운 메이크업 미백 화장료를 제공하는 것이다.An object of the present invention is to provide a new makeup whitening cosmetics with excellent whitening effect and at the same time improved makeup and usability.

본 발명의 미백파우더는 미백 물질이 이산화티탄 실리카에 흡착되어 있고 그위에 실리콘 공중합체가 2중 코팅된 파우더이다(제 1 도).The whitening powder of the present invention is a powder in which a whitening material is adsorbed on titanium dioxide silica and a double coated silicone copolymer thereon (FIG. 1).

이때, 미백 물질에는 하루노사이드, 아스코르빅산, 코직산, 코직산 유도체, 하이드로 퀴논, 알부틴 및 미백효과가 알려진 식물 추출물 등의 멜라닌 생성 억제물질중에서 선택될 수 있으며, 바람직하게는 하루노사이드이다.In this case, the whitening substance may be selected from melanin production inhibitors such as harunoside, ascorbic acid, kojic acid, kojic acid derivatives, hydroquinone, arbutin and plant extracts known for whitening effects, and are preferably harunosides.

이산화티탄 실리카는 친수성이고 자외선 차단 효과가 높다.Titanium dioxide silica is hydrophilic and has a high UV protection effect.

실리카 공중합체는 폴리 실록산 공중합체로, 트리메칠 폴리 실록산, 메칠히드로젠 폴리 실록산 및 가교형 메칠 폴리 실록산 중에서 1종이 선택되며, 내수성 및 피부 부착력이 강하다.The silica copolymer is a polysiloxane copolymer, and one of trimethyl polysiloxane, methylhydrogen polysiloxane, and crosslinked methyl polysiloxane is selected, and water resistance and skin adhesion are strong.

따라서 본 발명의 미백 파우더는 미백효과가 우수하며 자외선 차단효과가 높으며, 내수성 및 피부 부착력이 우수하다.Therefore, the whitening powder of the present invention is excellent in whitening effect, high UV protection effect, excellent in water resistance and skin adhesion.

또한 본 발명의 미백 파우더의 제조방법은 입자 크기가 2 - 30 ㎛인 이산화티탄 실리카 70-94.5 중량%에 50% 미백물질의 용액 5-25 중량%를 흡착시킨 후, 실리카 공중합체 0.5-5 중량%로 코팅하고, 100-150 ℃ 및 800-1000 기압에서 24-43 시간 동안 숙성시킨 후 분쇄 2회시키고 친유처리하는 것이다.In addition, the method for producing a whitening powder of the present invention is adsorbed 5-25% by weight of a solution of 50% whitening material to 70-94.5% by weight of titanium dioxide silica having a particle size of 2-30 ㎛, 0.5-5 weight of silica copolymer Coated in%, aged at 100-150 ° C. and 800-1000 atm for 24-43 hours, followed by grinding twice and lipophilic.

또한, 50% 미백물질 용액의 용매는 에탄올, 메탄올, 프로필렌 글리콜, 1.3 부틸렌 글리콜 및 염화칼슘 용액 중에서 1종이 선택된다.In addition, the solvent of the 50% whitening solution is selected from ethanol, methanol, propylene glycol, 1.3 butylene glycol and calcium chloride solution.

또한 본 발명의 메이크업 미백 화장료는 미백 파우더 1-20 중량%를 함유하는 메이크업 미백 화장료를 제공한다.In addition, the makeup whitening cosmetic of the present invention provides a makeup whitening cosmetic containing 1-20% by weight of the whitening powder.

이때 메이크업 미백 화장료는 유화형 화운데이션, 오일케익형 화운데이션, 투웨이케익일 수 있다. 미백 화장료가 유화형 화운데이션인 경우에는 미백 파우더 함유량은 1-15 중량%가 바람직하며, 미백 파우더 1 중량% 이하이면 본 발명에서 목적하는 바를 달성할 수 없게되고 15 중량% 이상이면 더 이상의 내수성의 증가없이 안정성만 저해하게 된다.In this case, the makeup whitening cosmetic may be an emulsion type foundation, an oil cake type foundation, or a two-way cake. When the whitening cosmetic is an emulsified foundation, the whitening powder content is preferably 1-15% by weight, and when the whitening powder is 1% by weight or less, the object of the present invention cannot be achieved, and when the amount is 15% by weight or more, the water resistance is further increased. Only stability is impaired.

미백 화장료가 오일케익형 화운데이션이나 투웨이케익인 경우에는 미백 파우더 함유량은 2 - 20 중량%가 바람직하며, 미백 파우더 2 중량% 이하이면 미백 효과, 자외선 차단 효과, 내수성이 없고, 20 중량% 이상이면 투웨이케익의 케이크 성형 능력이 떨어지며 오일케익형 화운데이션의 내수성이 더 이상 증가하지 않는다.When the whitening cosmetic is an oil cake type foundation or a two-way cake, the content of the whitening powder is preferably 2 to 20% by weight. If the whitening powder is 2% by weight or less, the whitening effect, the sunscreen effect, and the water resistance are not included, and the two-way is more than 20% by weight. The cake's ability to mold cake is reduced and the water resistance of the oil cake-type foundation no longer increases.

본 발명의 메이크업 미백 화장료는 미백효과, 화장효과 및 사용성이 뛰어나다.Makeup whitening cosmetics of the present invention is excellent in whitening effect, cosmetic effect and usability.

이하 본 발명을 실시예 및 실험예에 의하여 상세히 설명하나 본 발명의 내용이 이에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail with reference to Examples and Experimental Examples, but the content of the present invention is not limited thereto.

실시예 1Example 1

이산화티탄 실리카 80 중량%를 실온에서 프로펠러 믹서를 사용하여 20분간 혼합 교반한 후, 여기에 하루노사이드 50 중량%와 5% 염화칼슘용액 50 중량%를 혼합한 50% 하루노사이드 용액 15 중량%를 서서히 가하면서 혼합 분산하여 하루노사이드를 이산화티탄 실리카에 흡착시키고, 트리메칠 폴리 실록산 5 중량%를 가하고 교반 분산하여 코팅시킨 후, 120℃에서 24시간 동안 건조하였다. 얻어진 분체를 분쇄기로 2회 분쇄하여 미백 파우더를 얻었다.80% by weight of titanium dioxide silica was mixed and stirred at room temperature for 20 minutes using a propeller mixer, and then 50% by weight of 50% by weight of Harunoside and 50% by weight of 5% calcium chloride solution were slowly added thereto. The mixture was dispersed and adsorbed while adsorbing Harunoside to titanium dioxide silica, 5% by weight of trimethyl polysiloxane was added thereto, followed by coating with stirring and dispersion, followed by drying at 120 ° C for 24 hours. The obtained powder was pulverized twice with a grinder to obtain a whitening powder.

실시예 2Example 2

이산화티탄 실리카 90 중량%와 50% 하루노사이드 용액 5 중량%를 제외하고는, 실시예 1과 같은 방법으로 제조하였다.Except for 90% by weight of titanium dioxide silica and 5% by weight of 50% Harunoside solution, it was prepared in the same manner as in Example 1.

실시예 3Example 3

이산화티탄 실리카 70 중량%와 50% 하루노사이드 용액 25 중량%를 제외하고는, 실시예 1과 같은 방법으로 제조하였다.Except for 70% by weight of titanium dioxide silica and 25% by weight of 50% Harunoside solution, it was prepared in the same manner as in Example 1.

실시예 4Example 4

50% 하루노사이드 용액 19.5 중량%와 트리메칠 폴리 실록산 0.5 중량%를 제외하고는, 실시예 1과 같은 방법으로 제조하였다.It was prepared in the same manner as in Example 1, except 19.5% by weight of 50% Harunoside solution and 0.5% by weight of trimethyl polysiloxane.

실시예 5Example 5

트리메칠 폴리 실록산 대신 메칠 히드로젠 폴리 실록산을 사용하는 것을 제외하고는, 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1, except that methyl hydrogen polysiloxane was used instead of trimethyl polysiloxane.

실시예 6Example 6

트리메칠 폴리 실록산 대신 가교형 메칠 실록산을 사용하는 것을 제외하고는, 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1 except for using crosslinked methyl siloxane instead of trimethyl polysiloxane.

실시예 7Example 7

50% 하루노사이드 용액의 용매로 5% 염화칼슘용액 대신 메탄올을 사용하는 것을 제외하고는, 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1, except that methanol was used instead of the 5% calcium chloride solution as the solvent of the 50% Harunoside solution.

실시예 8Example 8

50% 하루노사이드 용액의 용매로 5% 염화칼슘용액 대신 에탄올을 사용하는 것을 제외하고는, 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1 except that ethanol was used instead of 5% calcium chloride solution as the solvent of the 50% Harunoside solution.

실시예 9Example 9

50% 하루노사이드 용액의 용매로 5% 염화칼슘용액 대신 프로필렌 글리콜을 사용하는 것을 제외하고는, 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1 except for using propylene glycol instead of 5% calcium chloride solution as the solvent of the 50% Harunoside solution.

실시예 10Example 10

50% 하루노사이드 용액의 용매로 5% 염화칼슘용액 대신 1,3 부틸렌 글리콜을 사용하는 것을 제외하고는, 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1, except that 1,3 butylene glycol was used instead of 5% calcium chloride solution as the solvent of the 50% Harunoside solution.

비교예 1Comparative Example 1

하루노사이드가 함유되지 않은 파우더로서, 이산화티탄 실리카 파우더를 사용하였다.Titanium dioxide silica powder was used as the powder containing no Harunosides.

실험예 1 : 하루노사이드 흡착과 실리콘 공중합체의 코팅 확인Experimental Example 1 Harunoside Adsorption and Coating Confirmation of Silicone Copolymer

이산화티탄 실리카에 하루노사이드를 흡착시킨 후 실리콘 공중합체를 2차 코팅시켜 미백 파우더를 제조함에 있어서, 하루노사이드의 흡착과 실리콘 공중합체의 코팅 상태를 확인하기 위하여 다음과 같이 실험하였다.In preparing the whitening powder by adsorbing Harunoside on titanium dioxide silica and coating the copolymer with silicone, the experiment was carried out as follows to confirm the adsorption of Harunoside and the coating state of the silicone copolymer.

하루노사이드 흡착 여부는 실시예에서 제조한 미백 파우더를 0.1N 염산이나 에탄올에 용해시켜 실리콘 중합체를 제거한 후 하루노사이드가 물쪽으로 흘러 나오는양을 적정하여 확인하였다.Adsorption of Harunoside was confirmed by dissolving the whitening powder prepared in Example in 0.1N hydrochloric acid or ethanol to remove the silicone polymer and then titrating the amount of the Harunoside flowing to the water.

실리콘 공중합체의 코팅 여부는 미백 파우더를 20%가 되게 10% 염화나트륨 용액에 담근 후 1일 이상 침전시켜 침전되는 파우더의 유무로 확인하였는데, 이는 코팅이 되어 친유처리됨을 나타낸다.The coating of the silicone copolymer was confirmed by the presence or absence of powder precipitated by soaking the whitening powder in 20% 10% sodium chloride solution to 20%, which precipitates, indicating that the coating is lipophilic.

그 결과 모든 미백 파우더에서 하루노사이드가 흡착되었고, 실리콘 공중합체가 2차 코팅되어 있음을 확인하였다.As a result, it was confirmed that Harunoside was adsorbed on all the whitening powders, and that the silicone copolymer was coated secondary.

실험예 2 : 티로시나아제 활성 저해 효과 확인Experimental Example 2: Confirmation of the inhibitory effect of tyrosinase activity

하루노사이드이 티로시나제 활성 저해 효과를 측정하였다.Harunoside measured the inhibitory effect of tyrosinase activity.

티로시나제는 버섯(mushroom)에서 분리 정제된 것으로 시그마(Sigma)사에서구입하여 사용하였다. 기질인 티로신은 0.05 M 인산나트륨 완충용액(pH 6.8)에 녹여 0.1mg/㎖ 용액으로 만들어 사용하였다. 하루노사이드는 실시예에서 제조한 미백 파우더를 에탈올에 용해시킨후 빠져나온 하루노사이드 용액을 완충용액에 희석하여 사용하였다.Tyrosinase was purified from mushrooms and used by Sigma. Tyrosine, a substrate, was dissolved in 0.05 M sodium phosphate buffer (pH 6.8) and used as a 0.1 mg / ml solution. Harunoside was used by diluting the whitening powder prepared in Example in ethanol and then releasing the extracted Harunoside solution in a buffer solution.

티로신 용액 0.5㎖을 시험관에 넣고 여기에 하루노사이드 시료용액 0.5㎖을 가하고 37 ℃에서 10분간 방치한 후, 300 U/㎖ 티로시나제 0.5㎖을 넣고 37℃에서 10분간 반응시켰다. 이때 대조군은 완충용액 0.5㎖을 넣은 것이다. 이 반응액이 든 시험관을 얼음속에 넣어서 급냉시켜, 반응을 중지시키고 분광광도계로 파장 475 nm에서의 흡광도를 측정하였다.0.5 ml of tyrosine solution was added to a test tube, and 0.5 ml of a Harunoside sample solution was added thereto, and left at 37 ° C. for 10 minutes. Then, 0.5 ml of 300 U / ml tyrosinase was added thereto and reacted at 37 ° C. for 10 minutes. At this time, the control group is 0.5ml of buffer solution. The test tube containing the reaction solution was placed in ice and quenched to stop the reaction, and the absorbance at 475 nm was measured with a spectrophotometer.

하루노사이드의 티로시나제 활성 저해 효과는 하기의 공식으로 구한다.The inhibitory effect of tyrosinase activity of Harunoside is obtained by the following formula.

티로시나제 활성 저해율(%) = 100 - [(시료의 흡광도/대조군 흡광도) × 100]% Inhibition of tyrosinase activity = 100-[(absorbance of sample / control absorbance) × 100]

실험 결과는 하기의 표 1에 나타난 바와 같다.The experimental results are shown in Table 1 below.

표 1. 미백 파우더에 함유된 하루노사이드의 티로시나제 활성 저해 효과Table 1. Inhibitory Effects of Harunosides on Tyrosinase Activity in Whitening Powders

Figure pat00001
Figure pat00001

실험예 3 : 세포 독성 및 멜라닌 생성 억제 작용 확인Experimental Example 3: Confirmation of cytotoxicity and melanin production inhibitory effect

색소 세포에 대한 세포 독성과 멜라닌 생성 억제 작용을 측정하였다.Cytotoxicity and melanogenesis inhibitory effects on pigment cells were measured.

MB-16 멜라노마 세포를 5×104세포로 10% 혈청을 함유하는 DMEM배지에 접종하고 T-플라스크(75cm2)에서 24시간 배양한 후, 새로운 배지와 실시예의 미백 파우더를 배양세포에 첨가한 후 2일간 배양한다. 배양 후 배지를 제거하고 인산 완충용액으로 세정하고 트립신을 처리하여 세포를 분리시킨다. 원심 분리기로 세포를 수집하여 일부는 MTT 분석하여 세포 독성을 측정한다. 일부 세포는 5% 트리클로로아세트산으로 처리한 후, 1N NaOH로 용해시켜 475nm에서 멜라닌 함량을 측정한다.MB-16 melanoma cells were inoculated in DMEM medium containing 10% serum with 5 × 10 4 cells and incubated for 24 hours in a T-flask (75 cm 2 ), followed by adding fresh medium and the whitening powder of Example to the culture cells. Incubate for 2 days. After incubation, the medium is removed, washed with phosphate buffer and trypsin treated to separate cells. Cells are collected by centrifuge and some are measured for cytotoxicity by MTT assay. Some cells are treated with 5% trichloroacetic acid and then lysed with 1N NaOH to measure melanin content at 475 nm.

실험 결과는 하기 표 2에 나타난 바와 같다.Experimental results are shown in Table 2 below.

표 2. 세포 독성과 멜라닌 생성 억제율Table 2. Cytotoxicity and Melanin Inhibition Rate

Figure pat00011
Figure pat00011

*세포 독성은 대조군의 세포수를 100으로하여 100%로 계산* Cytotoxicity is calculated as 100% with 100 cells

처방예 1-3 : 유화형 화운데이션Prescription Example 1-3: Emulsion Type Foundation

다음 표 3의 성분 및 조성비에 따라 유화형 화운데이션을 제조하되, 안료를 오일상에 분산시킨 후 수상을 첨가하여 유화시키고 냉각 탈포시켜서 제조한다. 이때 비교처방예 1 은 실시예 1의 미백 파우더 대신 비교예의 파우더를 사용하여 제조한 것이다.Next, an emulsion type foundation is prepared according to the components and the composition ratios of Table 3, which is prepared by dispersing the pigment in an oil phase, emulsifying by adding an aqueous phase, and cooling and defoaming. At this time, Comparative Example 1 is prepared using the powder of the comparative example instead of the whitening powder of Example 1.

표 3. 처방예 1-3의 유화형 화운데이션의 조성비Table 3. Composition ratio of emulsion type foundation of Formulation Examples 1-3

Figure pat00003
Figure pat00003

처방예 4-6 : 오일케익형 화운데이션Prescription 4-6: Oil Cake-type Foundation

다음 표 4 의 성분 및 조성비에 따라 오일 케익형 화운데이션을 제조하되, 안료를 오일상에 분산시킨 후 향을 첨가하여 접시에 충진시킨 다음 냉각시켜 제조한다. 이때 비교처방예 2는 실시예 1의 미백 파우더 대신 비교예의 파우더를 사용하여 제조한 것이다.Next, an oil cake-type foundation is prepared according to the components and the composition ratios of Table 4, and the pigment is dispersed in an oil phase, and then charged to a dish by adding flavor and then cooled to prepare. At this time, Comparative Prescription 2 was prepared using the powder of Comparative Example instead of the whitening powder of Example 1.

표 4. 처방예 4-6의 오일케익형 화운데이션의 조성비Table 4. Composition ratio of oil cake type foundation of prescription example 4-6

Figure pat00004
Figure pat00004

처방예 7-9 : 투웨이케익Prescription 7-9: Two-way cake

다음 표 5의 성분 및 조성비에 따라 투웨이케익(유중수적 케익형 화운데이션)을 제조하되, 안료를 혼합 분쇄시킨 후 유성성분, 첨가제 및 향을 투입하여 혼합 분쇄후 성형타정하여 제조한다. 이때 비교처방예 3은 실시예 1의 미백 파우더 대신 비교예의 파우더를 사용하여 제조한 것이다.Next, the two-way cake (water-in-oil cake-based foundation) is prepared according to the ingredients and composition ratios of Table 5, and after mixing and grinding the pigments, the oil-based ingredients, additives, and flavors are added to prepare the tablets after mixing and grinding. At this time, Comparative Preparation Example 3 is prepared using the powder of Comparative Example instead of the whitening powder of Example 1.

표 5. 처방예 7-9의 투웨이케익의 조성비Table 5. Composition ratio of two-way cake of Prescription Example 7-9

Figure pat00005
Figure pat00005

처방예 1-9의 색소 침착 억제 효과Pigmentation Inhibitory Effect of Prescription Example 1-9

건강한 남녀 20명의 실험 대상자의 양팔 하박부에 2×2 cm2부위를 설정하였다. 실험 대상 부위에만 자외선이 조사되도록 호일을 팔에 씌우고, 10cm의 거리에서 일본 도시바(주)의 FL 20S BLB 램프를 1m w/cm2/sec 1회로 4분간 조사하였다. 조사전에 실험대상 부위를 70% 이소프로필알콜 수용액으로 잘 세척하였다. 조사후 자외선 조사 부위에 상기 실시예 파우더를 함유한 처방예와 비교처방예 를 1일에 3회씩 도포하였다. 3주 도포 후에 육안으로 색소 침착도를 판정하고, 색소 침착을 얼마나 억제하였는가를 현저한 효과, 유효, 부효의 3단계로 평가 하였다.A 2 × 2 cm 2 site was set in the lower arms of both arms of 20 healthy men and women. The foil was put on the arm so that ultraviolet rays were irradiated only to the test target site, and the FL 20S BLB lamp of Toshiba, Japan was irradiated at a distance of 10 cm for 4 minutes at 1 m w / cm 2 / sec once. Before the irradiation, the test site was washed well with 70% isopropyl alcohol solution. After irradiation, a prescription example and a comparative prescription containing the Example powder were applied to the UV irradiation site three times a day. After three weeks of application, the degree of pigmentation was visually determined, and the degree of inhibition of pigmentation was evaluated in three steps: remarkable effect, effectiveness, and side effect.

그 결과는 하기의 표 6과 같다.The results are shown in Table 6 below.

표 6. 메이크업 미백 화장료의 피부 색소 침착 억제 효과Table 6. Effects of Skin Pigmentation on Makeup Whitening Cosmetics

화장효과 및 사용성 평가Cosmetic effect and usability evaluation

상기 처방예에 따른 화장료에 대한 화장효과 및 사용성 평가에 있어서, 자외선 차단 효과와 지속성, 내수성 및 안정성은 기기적으로 측정하였고 사용성, 안정성에 대해서는 20 내지 30세의 여성 100명을 대상으로하여 관능평가도 동시에 실시 하였다.In evaluating the cosmetic effect and usability of the cosmetic according to the prescription example, the sunscreen effect and the persistence, water resistance and stability were measured mechanically and the sensory evaluation of 100 women aged 20 to 30 for usability and stability. Also carried out simultaneously.

(1) 자외선 차단 효과(1) UV protection effect

석영판을 피부로 간주하고, 석영판위에 일정한 두께로 시료를 도포하여 얇은 막(film)을 형성시킨 후, 분광광도계로 이 막의 흡광도 및 투과도를 측정하였다. 또한 피마자유를 기재로 하여 상기 시료를 10%, 농도로 제조한 후 균일한두께(0.005 내지 0.01)의 막(film)을 형성시켜서 흡광도 및 투과도를 측정 290 - 400 nm의 값을 얻어 면적비로 산출한다.The quartz plate was regarded as skin, and a sample was applied on the quartz plate to a certain thickness to form a thin film, and then the absorbance and transmittance of the membrane were measured with a spectrophotometer. In addition, the sample was prepared at 10% and concentration based on castor oil, and then a film having a uniform thickness (0.005 to 0.01) was formed to obtain absorbance and transmittance. do.

(2) 지속성 효과(2) lasting effect

색차계(Colorimeter)를 이용하여 일정한 시간 간격으로 화장품 도포 전후의 색이 변하는 정도를 측정하였다. 이때 팔 부위를 10개 부위로 나누어 동일 면적 (25cm2)에 동일량(0.05 g)을 도포하여 지속성을 평가 하였고, 관능 평가도 동시에 실시하였다.The color change was measured using a colorimeter at regular time intervals. At this time, the arm was divided into 10 sites and the same amount (0.05 g) was applied to the same area (25 cm 2 ) to evaluate the sustainability, and sensory evaluation was also performed at the same time.

(3) 내수성 효과(3) water resistance effect

1) 색차계(Colorimeter)를 이용하여 일정한 시간 간격으로 화장품 도포 전후의 색이 변하는 정도를 측정하였다. 팔 부위를 10개 부위로 나누어 동일 면적에 동일량을 도포하여 도포전 피부색을 측정하였고, 도포후 피부색에 대해서는 10분 간격으로 물에 1분씩 담근 뒤 건조시켜 색의 변화도를 측정하였고, 관능 평가도 동시에 실시하였다.1) The degree of color change before and after cosmetic application was measured at regular time intervals using a colorimeter. The skin color was measured before application by dividing the arm into 10 parts and applying the same amount to the same area. After application, the skin color was soaked for 1 minute in water every 10 minutes and dried to measure the degree of color change. Also carried out simultaneously.

2) 유리판위에 화장품을 일정하게 도포하고, 그위로 40℃ 온도의 식염수를 30분동안 흘려보낸 뒤 남은 화장품의 양을 측정 평가하였다.2) The cosmetics were uniformly applied on the glass plate, and then the amount of cosmetics remaining after the flow of saline at 40 ° C. for 30 minutes was measured and evaluated.

(4) 안정성(4) stability

화장품을 40℃와 영하 10℃에서 하루동안 방치시키는 순환 온도법을 사용하여 관찰하고 유화가 파괴되는 시점의 순환 횟수에 따라 평가하였다.Cosmetics were observed using a circulating temperature method that was left at 40 ° C. and minus 10 ° C. for one day, and evaluated according to the number of cycles at which emulsification was destroyed.

그 결과는 하기의 표 7, 8 및 9에 나타내었다.The results are shown in Tables 7, 8 and 9 below.

표 7. 처방예 1-3의 유화형 화운데이션의 화장효과 및 사용성Table 7. Cosmetic Effect and Usability of Emulsion Type Foundation of Formulation Examples 1-3

Figure pat00007
Figure pat00007

표 8. 처방예 4-6의 오일케익형 화운데이션의 화장효과 및 사용성Table 8. Cosmetic Effect and Usability of Oil Cake-based Foundation of Prescription 4-6

Figure pat00008
Figure pat00008

표 9. 처방예 7-9의 투웨이케익의 화장효과 및 사용성Table 9. Cosmetic Effect and Usability of Two-Way Cake of Prescription Example 7-9

Figure pat00009
Figure pat00009

상기 처방예들을 종합해 보면, 이산화티탄 실리카에 하루노사이드를 흡착시킨 파우더에 실리콘 공중합체를 코팅시켜, 메이크업 화장료(유화헝 화운데이션, 오일 케익형, 투웨이 케익)에 사용한 결과 색소 침착 억제 및 지속성, 내수성, 사용성면에서 모두 우수 하였다.Putting together the above formulations, the coating of silicone copolymer on powder adsorbed Harunoside on titanium dioxide silica, used in make-up cosmetics (emulsion foundation, oil cake type, two-way cake), inhibiting pigmentation and sustainability, water resistance It was excellent in both usability and usability.

제 1 도는 미백 파우더의 단면을 나타내는 그림이다.1 is a diagram showing a cross section of the whitening powder.

Claims (7)

미백 물질이 이산화티탄 실리카에 흡착되어 있고 그위에 실리콘 공중합체가 2중 코팅된 미백 파우더.Whitening powder with whitening material adsorbed on titanium dioxide silica and double coated silicone copolymer on it. 제 1 항에 있어서, 미백 물질이 하루노사이드임을 특징으로 하는 미백 파우더.2. The whitening powder of claim 1, wherein the whitening material is harunoside. 제 1 항에 있어서, 실리콘 공중합체가 트리메칠 폴리실록산, 메칠 히드로젠 폴리실록산 및 가교형 메칠 폴리실록산중 1종이 선택됨을 특징으로 하는 미백 파우더.2. The whitening powder of claim 1, wherein the silicone copolymer is selected from trimethyl polysiloxane, methyl hydrogen polysiloxane and crosslinked methyl polysiloxane. 입자 크기가 2 - 30 ㎛인 이산화티탄 실리카 70-94.5 중량%에 50% 미백물질 용액 5-25 중량%를 흡착시킨 후, 실리카 공중합체 0.5-5 중량%로 코팅하고, 100-150℃ 및 800-1000 기압에서 24-48 시간 동안 숙성시킨 후 분쇄 2회시키고 친유처리하는 미백 파우더의 제조방법.After adsorbing 5-25% by weight of a 50% whitening solution on 70-94.5% by weight of titanium dioxide silica having a particle size of 2-30 μm, it was coated with 0.5-5% by weight of a silica copolymer, and then 100-150 ° C. and 800 Method of producing a whitening powder which is aged at -1000 atm for 24-48 hours and then pulverized twice and lipophilic. 제 4 항에 있어서, 미백 물질의 용액의 용매가 에탄을, 메탄올, 프로필렌 글리콜, 1,3 부틸렌 글리콜, 염화칼슘 용액 중에서 1종이 선택됨을 특징으로 하는 미백 파우더의 제조방법.The method for producing a whitening powder according to claim 4, wherein the solvent of the solution of the whitening material is ethane, one selected from methanol, propylene glycol, 1,3 butylene glycol, and calcium chloride solution. 제 1 항의 미백 파우더 1-20 중량%를 함유하는 메이크업 미백 화장료.Makeup whitening cosmetic containing 1-20 weight% of whitening powder of Claim 1. 제 6 항에 있어서, 메이크업 미백 화장료가 유화형 화운데이션, 오일케익형 화운데이션, 투웨이케익중에서 선택되는 것임을 특징으로하는 메이크업 미백 화장료.The makeup whitening cosmetic according to claim 6, wherein the makeup whitening cosmetic is selected from an emulsion type foundation, an oil cake type foundation, and a two-way cake.
KR1019970008310A 1997-03-12 1997-03-12 Skin-whitening powder, preparation process thereof and skin-whitening makeup cosmetic containing the same powder KR100372233B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019970008310A KR100372233B1 (en) 1997-03-12 1997-03-12 Skin-whitening powder, preparation process thereof and skin-whitening makeup cosmetic containing the same powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019970008310A KR100372233B1 (en) 1997-03-12 1997-03-12 Skin-whitening powder, preparation process thereof and skin-whitening makeup cosmetic containing the same powder

Publications (2)

Publication Number Publication Date
KR19980073162A KR19980073162A (en) 1998-11-05
KR100372233B1 true KR100372233B1 (en) 2003-06-11

Family

ID=37416609

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970008310A KR100372233B1 (en) 1997-03-12 1997-03-12 Skin-whitening powder, preparation process thereof and skin-whitening makeup cosmetic containing the same powder

Country Status (1)

Country Link
KR (1) KR100372233B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100817145B1 (en) * 2001-02-23 2008-03-27 코세 코퍼레이션 A porous titanium oxide·organopolysiloxane hybrid powder and titanium oxide·silica complex and a cosmetic composition therewith

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100341638B1 (en) * 2000-03-17 2002-06-22 유상옥,송운한 Method of Producing The Surface Treated Functional Pigment for Make-up Cosmetics and The Make-up Cosmetics Containing That
KR100786706B1 (en) * 2002-02-20 2007-12-21 (주)아모레퍼시픽 Emulsifier-free UV protecting cosmetic compositions of the oil-in-water type which has water splash appearance and a method of preparing thereof
KR100611647B1 (en) * 2004-07-15 2006-08-14 부경대학교 산학협력단 Silica coating method of TiO2 as ultraviolet shielding material to prevent photocatalytic activity and to disperse at solution
KR100820238B1 (en) 2006-11-27 2008-04-07 (주)아모레퍼시픽 High spf powder foundation cosmetic composition
WO2012057374A1 (en) * 2010-10-26 2012-05-03 바이오제닉스(주) Multi-functional cosmetic composition and preparation method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6344510A (en) * 1986-08-11 1988-02-25 Kobayashi Kooc:Kk Makeup cosmetic
KR910003103A (en) * 1989-07-25 1991-02-26 스미스클라인 바이오로지컬스(에스. 에이) New antigens and methods for them
KR910003105A (en) * 1989-07-19 1991-02-26 그뤼넨탈 게엠베하 Plasmids, methods for their construction, and their use in the production of plasminogen activators
JPH07228515A (en) * 1994-02-16 1995-08-29 Pola Chem Ind Inc Ultraviolet-shielding cosmetic
JPH08277208A (en) * 1995-04-05 1996-10-22 Sumitomo Chem Co Ltd Make-up cosmetic
KR19980069434A (en) * 1997-02-28 1998-10-26 이능희 Cosmetic pigments having a moisturizing effect and solid powder color cosmetics containing the same

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6344510A (en) * 1986-08-11 1988-02-25 Kobayashi Kooc:Kk Makeup cosmetic
KR910003105A (en) * 1989-07-19 1991-02-26 그뤼넨탈 게엠베하 Plasmids, methods for their construction, and their use in the production of plasminogen activators
KR910003103A (en) * 1989-07-25 1991-02-26 스미스클라인 바이오로지컬스(에스. 에이) New antigens and methods for them
JPH07228515A (en) * 1994-02-16 1995-08-29 Pola Chem Ind Inc Ultraviolet-shielding cosmetic
JPH08277208A (en) * 1995-04-05 1996-10-22 Sumitomo Chem Co Ltd Make-up cosmetic
KR19980069434A (en) * 1997-02-28 1998-10-26 이능희 Cosmetic pigments having a moisturizing effect and solid powder color cosmetics containing the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100817145B1 (en) * 2001-02-23 2008-03-27 코세 코퍼레이션 A porous titanium oxide·organopolysiloxane hybrid powder and titanium oxide·silica complex and a cosmetic composition therewith

Also Published As

Publication number Publication date
KR19980073162A (en) 1998-11-05

Similar Documents

Publication Publication Date Title
KR100372233B1 (en) Skin-whitening powder, preparation process thereof and skin-whitening makeup cosmetic containing the same powder
JPH0930946A (en) Beautifying and whitening dermal preparation for external use
KR100521768B1 (en) Cosmetic Compositions for a Skin Whitening
JP2749218B2 (en) Cosmetic composition for whitening
JPH10330219A (en) Melanogenesis inhibitor and skin whitening agent
JPH049316A (en) Whitening cosmetic
JPH0930954A (en) Beautifying and whitening dermal preparation for external use
JPH0812561A (en) Beautifying and whitening skin preparation for external use
JPH0925209A (en) Skin preparation for external use
JPH0930945A (en) Dermal preparation for external use
JPH0812549A (en) Skin external preparation
JPH0930949A (en) Beautifying and whitening dermal preparation for external use
JPH0812552A (en) Skin external preparation
KR100415278B1 (en) Skin whitening compositions using the Fragrance
JPH0987135A (en) Dermal preparation for external use
JP3512143B2 (en) Melanin production inhibitor and whitening agent
TWI732786B (en) Skin external composition for anti-aging comprising cyanidin-3-o-glucoside and natto gum
JPH0995436A (en) Preparation for external use for skin
JPH0920635A (en) Whitening skin preparation for external use
KR20070079390A (en) Cosmetic composition for skin whitening
JPH11246344A (en) Preparation for external use for skin bleaching
JPH0812550A (en) Skin external preparation
JPH0812564A (en) Skin external preparation
KR101599482B1 (en) Composition comprising comprising the liquiritigenin for prevention and treatment of vitiligo
JPH0812557A (en) Skin external preparation

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130111

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20131127

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20150112

Year of fee payment: 13

FPAY Annual fee payment

Payment date: 20151211

Year of fee payment: 14

FPAY Annual fee payment

Payment date: 20161227

Year of fee payment: 15

EXPY Expiration of term